FDA approves Chinese eye cancer treatment for development support in the US
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment incentives.